Sunday, November 16, 2014

Radiologists perform better at screening if they follow up with diagnostic mammograms

Buist et al in their Radiology article analyzed the performance of 96 radiologists at screening mammograms (651 671).  They looked at the effect the number of diagnostic work-ups performed after abnormal findings were found at screening had if the same or a different radiologist interpreted them.

Annually, 38% of radiologists performed the diagnostic work-up for 25 or fewer of their own recalled screening mammograms, 24% for 0–50, and 39% for more than 50. For the work-up of recalled screening mammograms from other radiologists, 24% of radiologists performed the work-up for 0–50 mammograms, 32% performed the work-up for 51–125, and 44% performed the work-up for more than 125.

With increasing numbers of radiologist work-ups for their own recalled mammograms, the sensitivity of screening mammography increased, yielding a stepped increase in women recalled per cancer detected from 17.4 for 25 or fewer mammograms to 24.6 for more than 50 mammograms. Increases in work-ups for any radiologist yielded significant increases in false positive rate and cancer detection rate and a non-significant increase in sensitivity. Radiologists with a lower annual volume of any work-ups had consistently lower false positive rate, sensitivity, and cancer detection rate at all annual interpretive volumes.


They conclude that radiologists may improve their screening accuracy by performing diagnostic work-up for their own recalled screening mammograms.  They recommend arranging for radiologists to work up a minimum number of their own recalled cases in order to improve their accuracy in screening.

Saturday, November 8, 2014

CT Screening for Lung Cancer may be Cost-Effective

Black et al in their article published by the NEJM report that findings from the National Lung Screening Trial, that was funded by the NCI, showed that screening with low-dose computed tomography as compared with chest radiography reduced lung-cancer mortality.

Their research team estimated mean life-years, quality-adjusted life-years (QALYs), costs per person, and incremental cost-effectiveness ratios (ICERs) for three alternative strategies: screening with low-dose CT, screening with radiography, and no screening. Estimations of life-years were based on the number of observed deaths that occurred during the trial and the projected survival of persons who were alive at the end of the trial. Quality adjustments were derived from a subgroup of participants who were selected to complete quality-of-life surveys. Costs were based on utilization rates and Medicare reimbursements. They also performed analyses of subgroups defined according to age, sex, smoking history, and risk of lung cancer and performed sensitivity analyses based on several assumptions.

As compared with no screening, screening with low-dose CT costs an additional $1,631 per person and provided an additional 0.0316 life-years per person and 0.0201 QALYs per person. The corresponding ICERs were $52,000 per life-year gained and $81,000 per QALY gained. However, the ICERs varied widely in subgroup and sensitivity analyses.


They concluded that screening for lung cancer with low-dose CT would cost $81,000 per QALY gained.  They also determined that modest changes in their assumptions would greatly alter this figure. The determination of whether screening outside the trial will be cost-effective will depend on how screening is implemented.

References
1.  Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold.  Peter J. Neumann, Sc.D., et al N Engl J Med 2014; 371:796-797August 28, 2014  http://www.nejm.org/doi/full/10.1056/NEJMp1405158
2.  On November 11, 2014 the U.S. Centers for Medicare and Medicaid Services (CMS) approved CT lung cancer screening for Medicare recipients, saying the evidence is sufficient to justify screening high-risk individuals until the age of 74 years.

Saturday, November 1, 2014

Tomosynthesis could be cost-effective for Breast Cancer Detection

Lee at al in their article in Radiology report on the effectiveness of combined biennial digital mammography and tomosynthesis, compared with biennial digital mammography alone to screen women aged 50-74 with dense breasts for breast cancer.

For the base-case analysis, the incremental cost per quality-adjusted life year gained by adding tomosynthesis to digital mammography screening was $53 893. An additional 0.5 deaths were averted and 405 false-positive findings avoided per 1000 women after 12 rounds of screening. Combined screening remained cost-effective (less than $100 000 per quality-adjusted life year gained) over a wide range of incremental improvements in test performance. Overall, cost-effectiveness was most sensitive to the additional cost of tomosynthesis.

Biennial combined digital mammography and tomosynthesis screening for U.S. women aged 50–74 years with dense breasts is likely to be cost-effective if priced appropriately (up to $226 for combined examinations versus $139 for digital mammography alone) and if the reported interpretive performance metrics of improved specificity with tomosynthesis are met in routine practice.


They concluded biennial digital mammography combined with tomosynthesis screening for women aged 50–74 years with dense breasts is likely to be cost-effective if priced appropriately (up to $226 for combined examinations versus $139 for digital mammography alone) and if specificity reported from tomosynthesis is achieved among the many practices across the country.

Saturday, October 25, 2014

Malpractice Reform does not Affect ED Utilization

Waxman et al report in NEJM their findings regarding the effect legal reform had in the practice of medicine, in three states, Texas, Georgia, and South Carolina, which between 2003 and 2005, enacted legislation that changed the malpractice standard for emergency care to gross negligence.  

Using a 5% random sample of Medicare fee-for-service beneficiaries, they identified all emergency department visits to hospitals in the three reform states and in neighboring (control) states from 1997 through 2011. They compared patient-level outcomes, before and after legislation, in reform states and control states. Outcomes were policy-attributable changes in the use of computed tomography (CT) or magnetic resonance imaging (MRI), per-visit emergency department charges, and the rate of hospital admissions.

For eight of the nine states–outcome combinations tested, they found no reduction in the rates of CT or MRI utilization or hospital admission in any of the three reform states and no reduction in charges in Texas or South Carolina. In Georgia, reform was associated with a 3.6% reduction in per-visit emergency department charges.


They conclude that legislation that substantially changed the malpractice standard for emergency physicians in three states had little effect on the intensity of practice, as measured by imaging rates, average charges, or hospital admission rates.

Saturday, October 18, 2014

Surgical Biopsies for Breast Cancer are Overused in the United States

Ebert et al in an article published by JCO report their findings from a review of Medicare data from 89,712 patients with breast cancer and 12,405 surgeons, regarding three outcomes: surgeon consultation before versus after biopsy, use of needle biopsy, and number of surgeries for cancer treatment.
Surgical biopsy was the standard for breast diagnosis before the 1990s, when most patients with breast cancer presented with clinical symptoms. The growth of mammographic screening in the 1980s significantly increased the number of non-palpable lesions found that required diagnostic work-up with either needle biopsy or surgical biopsy following needle localization. In their analysis the  authors looked at factors associated with surgeon consultation before biopsy, Medicaid coverage, rural residence, residence more than 8 miles from a radiologic facility performing needle biopsy, and no mammogram within 60 days before consultation. Among patients with surgeon consultation before biopsy, factors such as absence of board certification, training outside the United States, low case volume, earlier decade of medical school graduation, and lack of specialization in surgical oncology were negatively correlated with receipt of needle biopsy.
Overall, 68.4 percent had a needle biopsy and 31.6 had a surgical biopsy. If the patient's initial appointment was with a surgeon instead of a radiologist, the surgical biopsy rate grew to nearly 50 percent.  Surgeons less likely to refer patients for a needle biopsy were those without board certification, trained outside the U.S., graduated from medical school before 1980 or not specialized in surgical oncology.

The study found that 70 percent of patients who had an excisional biopsy required multiple surgeries while only 33 percent of patients who had needle biopsies did.

As in some countries like the United Kingdom diagnosis for breast cancers is now made with needle biopsy in 95% of the cases, the authors conclude that surgical biopsy is overused in the United States, and is having a negative impact on breast cancer diagnosis and treatment.